Chronic Fatigue Syndrome versus Systemic Exertion Intolerance Disease.
Jason, Leonard A, Sunnquist, Madison, Brown, Abigail et al. · Fatigue : biomedicine, health & behavior · 2015 · DOI
Quick Summary
Researchers compared different ways of diagnosing ME/CFS by testing 796 patients using a new diagnostic system called SEID (Systemic Exertion Intolerance Disease). They found that the new SEID criteria identified about 88% of patients, which is similar to an older diagnostic system but captures a larger group than some other definitions. The study suggests that different diagnostic criteria can identify different sizes and severity levels of patient populations.
Why It Matters
Diagnostic criteria directly affect who receives a diagnosis and what treatment or research opportunities they access. This study helps clarify that choosing different diagnostic definitions can significantly change which patients are identified and recognized, which has major implications for treatment access, research enrollment, and disease understanding.
Observed Findings
SEID criteria identified 88% of the study sample, compared to 92% using Fukuda criteria
The empirically derived four-item criteria identified a smaller subgroup with greater functional impairment and more symptoms
SEID criteria identified a larger patient population than both Canadian ME/CFS and ME-ICC criteria
Participants were recruited from tertiary care, biobanks, and online forums across three countries
All participants completed the DePaul Symptom Questionnaire as the measurement tool
Inferred Conclusions
SEID criteria capture a population size intermediate between the strict empiric criteria and the broader Fukuda criteria
The choice of diagnostic criteria meaningfully affects which patients are classified as having the disease and their average symptom severity
Narrower criteria like ME-ICC and Canadian ME/CFS definitions identify more severely affected subgroups than SEID
Case definitions serve different purposes and may identify clinically distinct populations depending on their requirements
Remaining Questions
Do the different patient groups identified by these criteria show distinct biological markers, disease trajectories, or treatment responses?
What This Study Does Not Prove
This study does not prove which diagnostic criteria is 'correct' or most clinically useful. It is a snapshot comparison using a single questionnaire and does not validate whether any criteria better predicts disease outcomes, treatment response, or underlying biological mechanisms. The study cannot establish which criteria most accurately captures the true disease biology.
Which diagnostic criteria best predicts clinical outcomes and prognosis for individual patients?
How do results generalize beyond the DePaul Symptom Questionnaire to clinical evaluation or other assessment instruments?
What is the clinical significance of capturing 88% versus 92% or smaller percentages—do patients just below each threshold have different treatment needs?